Tiziana Life Sciences Ltd. entered into a Separation and Release Agreement with Dr. Neil Graham, the Company's Chief Medical Officer, in connection with his resignation from the Company for personal reasons. In connection with entry into the Separation Agreement, the Executive and Company agreed to, among other things the Executive's release of all claims related to the Executive's employment with the Company and termination thereof.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.77 USD | +3.49% | +25.90% | +37.50% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+37.50% | 74.63M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Ltd. Enters into Separation and Release Agreement with Dr. Neil Graham, the Company’s Chief Medical Officer